Topamax Warning – Increased Risk of Cleft Palate in Newborns

more+
less-

Topamax is a prescription drug originally approved by the FDA in 1996 to treat epilepsy.The generic name is topiramate. Topamax is manufactured by Ortho-McNeil Neurologics, a subsidiary of Johnson & Johnson.

The FDA approved Topamax for use to treat migraines in 2004 and it is often prescribed off-label for bi-polar disorder.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Agency Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robert Kraft, Kraft & Associates | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »